Department of Clinical Electrophysiology, Erasmus Medical Center, Rotterdam, The Netherlands.
Cardiol Young. 2020 Sep;30(9):1231-1237. doi: 10.1017/S1047951120001900. Epub 2020 Jul 23.
Catheter ablation is an important therapeutic option for atrial tachycardias in patients with CHD. As a result of extensive scarring and surgical repair, multiple intra-atrial re-entrant tachycardia circuits develop and serve as a substrate for arrhythmias. The best ablation approach for patients with multiple intra-atrial re-entrant tachycardias has not been investigated. Here, we compared substrate-based ablation using extensive scar modification to conventional ablation.
The present study included patients with surgically corrected CHD that underwent intra-atrial re-entrant tachycardia ablation. Extensive scar modification was defined as substrate ablation based on a dense voltage map, aimed to eliminate all potentials in the scar region. The control group had activation mapping-based ablation. A clinical composite endpoint was assessed. Points were given for type, number, and treatment of intra-atrial re-entrant tachycardia recurrence.
In 40 patients, 63 (extensive scar modification 13) procedures were performed. Acute procedural success was achieved in 78%. Procedural duration was similar in both groups. Forty-nine percent had a recurrence within 1 year. During a 5-year follow-up (2.5-7.5 years), 46% required repeat catheter ablation. Compared to baseline, clinical composite endpoint significantly decreased by 46% after 12 months (p = 0.001). Acute procedural success, procedural parameters, recurrence and repeat ablation were similar between extensive scar modification and activation mapping-based ablation.
Catheter ablation using extensive scar modification for intra-atrial re-entrant tachycardias occurring after surgically corrected CHD illustrated similar short- and long-term outcomes and procedural efficiency compared to catheter ablation using activation mapping-based ablation. The choice of ablation approach for multiple intra-atrial re-entrant tachycardia should remain at the discretion of the operator.
导管消融是先天性心脏病(CHD)患者房性心动过速的重要治疗选择。由于广泛的瘢痕和手术修复,多个房内折返性心动过速环路形成,并作为心律失常的基质。对于有多个人房内折返性心动过速的患者,最佳的消融方法尚未得到研究。在这里,我们比较了基于基质的广泛瘢痕修饰消融与传统消融。
本研究纳入了接受房内折返性心动过速消融的手术矫正 CHD 患者。广泛的瘢痕修饰定义为基于密集电压图的基质消融,旨在消除瘢痕区域的所有电位。对照组进行激活图引导的消融。评估临床综合终点。为房内折返性心动过速的复发类型、数量和治疗方法给予评分。
在 40 例患者中,共进行了 63 次(广泛瘢痕修饰 13 次)手术。急性手术成功率为 78%。两组的手术时间相似。49%的患者在 1 年内复发。在 5 年的随访期(2.5-7.5 年)中,46%的患者需要再次导管消融。与基线相比,12 个月后临床综合终点显著下降 46%(p=0.001)。广泛瘢痕修饰与激活图引导消融相比,急性手术成功率、手术参数、复发和重复消融均相似。
对于手术矫正 CHD 后发生的房内折返性心动过速,导管消融使用广泛瘢痕修饰与激活图引导消融相比,显示出相似的短期和长期结果以及手术效率。对于多个房内折返性心动过速,消融方法的选择应取决于操作者的判断。